The eight abstract of one of the talks which will be held at our 2nd Symposium: "The Next 10 Years of Genome Content Management" on 29th March held at Cambridge, Babraham Research Campus.
The title is: Omics for cell therapies
Presented by: Alex Gutteridge, Pfizer
"The next generation of cell-based regenerative medicine therapies will require next generation approaches to questions of cell identity: How do we define and characterise different cell types generated in-vivo and in-vitro, how can we drive one cell type into another and how can we track cells once they enter the patient? The transcriptome, proteome, secretome,epigenome and genome, as well as phenomic high throughput imaging data, all have important roles to play in addressing these questions. I will discuss the challenges we face in terms of gathering, storing and disseminating these data in the research, clinical and production stages of our therapies.I will argue that establishing standards for defining cell identity is a fundamentally collaborative endeavour and discuss a number of ongoing collaborations we have around this area."